Clinical trial
Impact of Autologous Platelet-Rich Plasma on Promoting Bone Regeneration in Maxillary and Mandibular Fractures: A Randomized Controlled Trial
NCT07930026 is registered in ClinicalTrials.gov with CMH Lahore Medical College and Institute of Dentistry as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Autologous Platelet-Rich Plasma on Promoting Bone Regeneration in Maxillary and Mandibular Fractures: A Randomized Controlled Trial
- Lead sponsor
- CMH Lahore Medical College and Institute of Dentistry
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- June 2, 2026
- Completion date
- December 11, 2026
- Enrollment
- 40 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
Arms
As registered; 2 arms.
-
PRP + Miniplate Fixation
Patients undergo open reduction and internal fixation of the maxillary or mandibular fracture under general anaesthesia with two titanium miniplates and screws. Autologous platelet-rich plasma is prepared from 12 ml of the patient's venous blood by double centrifugation, activated with calcium chloride and bovine thrombin, and applied as a gel along the fracture line before wound closure. Postoperatively, patients receive antibiotics and anti-inflammatory medication for one week.
-
Miniplate Fixation Alone
Patients undergo open reduction and internal fixation of the maxillary or mandibular fracture under general anaesthesia with two titanium miniplates and screws, identical to the experimental arm, without application of platelet-rich plasma. Postoperatively, patients receive antibiotics and anti-inflammatory medication for one week.
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Bone Density at the Fracture Site
Mean bone density in Hounsfield units (HU) measured on cone-beam computed tomography (CBCT) within a 3 x 2.5 mm rectangular region of interest placed across the fracture line above the upper miniplate, using Planmeca software. Measurements are made by an assessor blinded to group allocation. Higher values indicate greater bone mineralization.
Lead sponsor's other trials
CMH Lahore Medical College and Institute of Dentistry, most recent start first.
+12 more trials See the organization page
Similar trials
Same condition (Maxillary Fractures) and phase, most recent start first.